State Street Corp F Star Therapeutics, Inc. Transaction History

State Street Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.0 - $7.12 $0 - $483,804	-67,950 Closed	0 $0
Q3 2022 Nov 15, 2022	BUY	$5.41 - $6.74 $80,068 - $99,752	14,800 Added 27.85%	67,950 $348,000
Q1 2022 May 16, 2022	BUY	$2.77 - $5.36 $19,888 - $38,484	7,180 Added 15.62%	53,150 $189,000
Q3 2021 Nov 15, 2021	BUY	$5.2 - $8.42 $108,680 - $175,978	20,900 Added 83.37%	45,970 $337,000
Q2 2021 Aug 16, 2021	BUY	$6.57 - $10.71 $164,709 - $268,499	25,070 New	25,070 $215,000

44.7K

Ticker FSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,584,700
Description
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.